Mechanism and Function for Subnuclear Targeting of Transcription Factors in Bone

$0P01FY2002ARNIH

Univ Of Massachusetts Med Sch Worcester, Worcester MA

Investigators

Linked publications & trials

Paper 25609707 Paper 25260661 Paper 25258250 Paper 25120271 Paper 25079347 Paper 25078095 Paper 25053011 Paper 24881813 Paper 24811921 Paper 24655370 Paper 24648201 Paper 24408924 Paper 24357537 Paper 24242872 Paper 23625810 Paper 23389849 Paper 22552993 Paper 22393235 Paper 22290358 Paper 22158627 Paper 21731849 Paper 21676869 Paper 21597276 Paper 21454629 Paper 21302301 Paper 21184003 Paper 21133844 Paper 20945391 Paper 20696837 Paper 20694661 Paper 20628351 Paper 20564179 Paper 20530675 Paper 20506188 Paper 20439491 Paper 20225274 Paper 20171279 Paper 20160071 Paper 20135643 Paper 20082326 Paper 20079730 Paper 19896493 Paper 19885846 Paper 19545172 Paper 19492418 Paper 19250187 Paper 19234518 Paper 19028669 Paper 19006109 Paper 18615590 Paper 18487609 Paper 18463823 Paper 18445650 Paper 18304030 Paper 18204048 Paper 18077419 Paper 17960593 Paper 17786964 Paper 17786950 Paper 17713577 Paper 17368182 Paper 17363043 Paper 17360627 Paper 17360458 Paper 17325044 Paper 17288986 Paper 17226779 Paper 17218095 Paper 17171635 Paper 17165130 Paper 17060321 Paper 17051438 Paper 17001681 Paper 16972259 Paper 16927309 Paper 16772287 Paper 16698796 Paper 16270353 Paper 16166639 Paper 16135382 Paper 16043491 Paper 15828028 Paper 15781466 Paper 15703179 Paper 15689940 Paper 15665096 Paper 15573378 Paper 15565649 Paper 15456894 Paper 15456860 Paper 15367579 Paper 15299011 Paper 15277516 Paper 15231660 Paper 15225783 Paper 15156188 Paper 15145777 Paper 15104525 Paper 14765127 Paper 14743389

Abstract

DESCRIPTION (provided by applicant): The long term goal of our studies is to understand control of gene expression in situ within the dynamic environment of the bone cell nucleus. During the past funding period, using the Runx transcription factors as a paradigm, we identified and initiated characterization of the first intranuclear trafficking signal that directs these osteogenic and hematopoietic regulatory proteins to punctate, nuclear matrix associated sites that support gene expression. This project will now combine molecular, biochemical, cellular, and in vivo genetic approaches to focus on establishing the developmental function and mechanisms by which Runx factors are targeted to distinct subnuclear foci where the regulatory machinery for transcription is recruited, assembled and organized. The findings from these studies will provide the in situ context for the integration of osteogenic signals (Project 2) into the molecular instructions required for controlling the chromatin packaging of bone phenotypic genes to establish competency for protein/DNA and protein/protein interactions that mediate activity (Project 3). The central hypothesis of our project is that the targeting of Runx2 to specific subnuclear foci is required for biological control of skeletal gene transcription. The specific aims are directed to establishing: (i) the, physiological requirement of Runx 2 subnuclear targeting for normal skeletal development and bone formation in vivo; (ii) the role of Runx2 intranuclear trafficking in osteoblast differentiation and bone specific gene transcription; (iii) the dynamics of targeting Runx2 and its co regulators to subnuclear foci in live cells in response to skeletal regulatory stimuli; and (iv) the molecular mechanisms that regulate intranuclear trafficking to Runx2 foci to support bone specific transcriptional control.

View original record on NIH RePORTER →